Multimodal sequential approach in colorectal cancer liver metastases

Hepatic resection after yttrium-90 selective internal radiation therapy and cetuximab rescue treatment

Sara Pini, Carmine Pinto, Bruna Angelelli, Emanuela Giampalma, Annabella Blotta, Francesca Di Fabio, Donatella Santini, Rita Golfieri, Andrea Angelo Martoni

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Synchronous or metachronous liver metastases occur in up to one-third of patients with colorectal cancer and are associated with a poor prognosis. Many evidences have shown that surgical resection can be curative, with 5-year survival rates ranging from37% to 50%, butmany patients are ineligible for surgery because ofmultiple liver lesions, bilobar distribution of liver metastases, or the presence of widespread extrahepatic disease. The management of unresectable liver metastases includes many therapeutic options such as systemic chemotherapy, selective internal radiation therapy (SIRT) with yttrium-90 (Y-90), targeted therapy, and surgery. These treatments can be integrated into a sequential multimodal approach to increase the resection rate.We present a case in which such an approach was put into practice. The favorable result suggests that SIRT, along with systemic chemotherapy and surgery, is a valid treatment option for unresectable colorectal liver metastases. Free full text available at www.tumorionline.it.

Original languageEnglish
Pages (from-to)157-159
Number of pages3
JournalTumori
Volume96
Issue number1
DOIs
Publication statusPublished - Jan 2010

Fingerprint

Yttrium
Liver Neoplasms
Colorectal Neoplasms
Radiotherapy
Neoplasm Metastasis
Liver
Therapeutics
Drug Therapy
Survival Rate
Cetuximab

Keywords

  • Colorectal cancer liver metastases
  • Selective internal radiation therapy
  • Yttrium-90

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Multimodal sequential approach in colorectal cancer liver metastases : Hepatic resection after yttrium-90 selective internal radiation therapy and cetuximab rescue treatment. / Pini, Sara; Pinto, Carmine; Angelelli, Bruna; Giampalma, Emanuela; Blotta, Annabella; Di Fabio, Francesca; Santini, Donatella; Golfieri, Rita; Martoni, Andrea Angelo.

In: Tumori, Vol. 96, No. 1, 01.2010, p. 157-159.

Research output: Contribution to journalArticle

Pini, Sara ; Pinto, Carmine ; Angelelli, Bruna ; Giampalma, Emanuela ; Blotta, Annabella ; Di Fabio, Francesca ; Santini, Donatella ; Golfieri, Rita ; Martoni, Andrea Angelo. / Multimodal sequential approach in colorectal cancer liver metastases : Hepatic resection after yttrium-90 selective internal radiation therapy and cetuximab rescue treatment. In: Tumori. 2010 ; Vol. 96, No. 1. pp. 157-159.
@article{59b62de7c1fb4a32a38d6d881362becb,
title = "Multimodal sequential approach in colorectal cancer liver metastases: Hepatic resection after yttrium-90 selective internal radiation therapy and cetuximab rescue treatment",
abstract = "Synchronous or metachronous liver metastases occur in up to one-third of patients with colorectal cancer and are associated with a poor prognosis. Many evidences have shown that surgical resection can be curative, with 5-year survival rates ranging from37{\%} to 50{\%}, butmany patients are ineligible for surgery because ofmultiple liver lesions, bilobar distribution of liver metastases, or the presence of widespread extrahepatic disease. The management of unresectable liver metastases includes many therapeutic options such as systemic chemotherapy, selective internal radiation therapy (SIRT) with yttrium-90 (Y-90), targeted therapy, and surgery. These treatments can be integrated into a sequential multimodal approach to increase the resection rate.We present a case in which such an approach was put into practice. The favorable result suggests that SIRT, along with systemic chemotherapy and surgery, is a valid treatment option for unresectable colorectal liver metastases. Free full text available at www.tumorionline.it.",
keywords = "Colorectal cancer liver metastases, Selective internal radiation therapy, Yttrium-90",
author = "Sara Pini and Carmine Pinto and Bruna Angelelli and Emanuela Giampalma and Annabella Blotta and {Di Fabio}, Francesca and Donatella Santini and Rita Golfieri and Martoni, {Andrea Angelo}",
year = "2010",
month = "1",
doi = "10.1700/479.5668",
language = "English",
volume = "96",
pages = "157--159",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Multimodal sequential approach in colorectal cancer liver metastases

T2 - Hepatic resection after yttrium-90 selective internal radiation therapy and cetuximab rescue treatment

AU - Pini, Sara

AU - Pinto, Carmine

AU - Angelelli, Bruna

AU - Giampalma, Emanuela

AU - Blotta, Annabella

AU - Di Fabio, Francesca

AU - Santini, Donatella

AU - Golfieri, Rita

AU - Martoni, Andrea Angelo

PY - 2010/1

Y1 - 2010/1

N2 - Synchronous or metachronous liver metastases occur in up to one-third of patients with colorectal cancer and are associated with a poor prognosis. Many evidences have shown that surgical resection can be curative, with 5-year survival rates ranging from37% to 50%, butmany patients are ineligible for surgery because ofmultiple liver lesions, bilobar distribution of liver metastases, or the presence of widespread extrahepatic disease. The management of unresectable liver metastases includes many therapeutic options such as systemic chemotherapy, selective internal radiation therapy (SIRT) with yttrium-90 (Y-90), targeted therapy, and surgery. These treatments can be integrated into a sequential multimodal approach to increase the resection rate.We present a case in which such an approach was put into practice. The favorable result suggests that SIRT, along with systemic chemotherapy and surgery, is a valid treatment option for unresectable colorectal liver metastases. Free full text available at www.tumorionline.it.

AB - Synchronous or metachronous liver metastases occur in up to one-third of patients with colorectal cancer and are associated with a poor prognosis. Many evidences have shown that surgical resection can be curative, with 5-year survival rates ranging from37% to 50%, butmany patients are ineligible for surgery because ofmultiple liver lesions, bilobar distribution of liver metastases, or the presence of widespread extrahepatic disease. The management of unresectable liver metastases includes many therapeutic options such as systemic chemotherapy, selective internal radiation therapy (SIRT) with yttrium-90 (Y-90), targeted therapy, and surgery. These treatments can be integrated into a sequential multimodal approach to increase the resection rate.We present a case in which such an approach was put into practice. The favorable result suggests that SIRT, along with systemic chemotherapy and surgery, is a valid treatment option for unresectable colorectal liver metastases. Free full text available at www.tumorionline.it.

KW - Colorectal cancer liver metastases

KW - Selective internal radiation therapy

KW - Yttrium-90

UR - http://www.scopus.com/inward/record.url?scp=77950810871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950810871&partnerID=8YFLogxK

U2 - 10.1700/479.5668

DO - 10.1700/479.5668

M3 - Article

VL - 96

SP - 157

EP - 159

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 1

ER -